Artivion | CRY - Current Liabilities


Artivion reported $76.66M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 76.66M 30.28M Sep/2026
AtriCure USD 83.97M 2.06M Sep/2026
Baxter International USD 3.81B 218M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Boston Scientific USD 5.98B 446M Sep/2026
Edwards Lifesciences USD 1.58B 68.8M Sep/2026
Inogen USD 64.94M 2.12M Sep/2025
Integra LifeSciences USD 329M 1.88M Sep/2026
J&J USD 55.46B 562M Sep/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 138.38M 18.62M Sep/2026
Pfizer USD 31.73B 920M Sep/2026
ResMed USD 1.32B 70.89M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Tandem Diabetes Care USD 256.08M 3.07M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Terumo JPY 306.08B 107.19B Sep/2026
Trinity Biotech USD 143.68M 2.48M Mar/2026